Chronic Respiratory Disease Clinical Trial
Official title:
Pharmacological Evaluation of Antifungal Drugs in Respiratory Samples of Patiens With Chronic Pulmonary Aspergillosis
At present, pulmonary diffusion and target antifungal concentrations for APC in patients with sarcoidosis or chronic obstructive pulmonary disease (COPD) are unknown.
Knowledge of these elements is however an essential prerequisite for optimizing the dosages in these contexts. The main objective of the study is to quantify the diffusion of antifungals in the lower respiratory tract in patients treated for pulmonary aspergillosis in the context of underlying chronic respiratory disease. Determining this level of diffusion will make it possible to deduce the plasma concentrations to be achieved in patients and to identify the molecules with the best diffusion profile. The concentration of antifungals in the lungs will be measured from 3 types of samples: - Sputum obtained by expectoration. These samples will make it possible to quantify the diffusion at the level of the upper and lower respiratory tree. - Bronchial aspirations. These samples will make it possible to quantify the diffusion at the level of the deep respiratory tree. - Bronchoalveolar lavage fluid, which will quantify the diffusion at the level of the deep respiratory tree and the ELF. Blood samples will be taken simultaneously so as to determine the percentage of diffusion from the plasma to the lung. All these samples will be taken as part of the standard care of patients, the lung samples having the main use of mycological monitoring, the blood samples having the main use of pharmacological and serological monitoring. Lung samples will also be taken routinely for pharmacological monitoring, in order to measure antifungal concentrations at the site of infection. Mycological monitoring will consist of measuring the fungal load in the broncho-respiratory secretions as well as carrying out an antifongigram in the event of isolation of Aspergillus spp. The possible association between plasma and pulmonary concentrations of antifungals on the one hand, and mycological and clinical markers of treatment efficacy on the other hand, will also be investigated. The mycological markers of efficacy will be the results of mycological monitoring (culture of broncho-respiratory secretions and aspergillus serology). The clinical markers will be the pulmonary imaging results obtained as part of the management of these patients. The identification of such combinations should allow target concentrations of antifungals to be defined and, where appropriate, antifungal dosage recommendations specific to the treatment of PCA in patients with chronic respiratory disease to be defined. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02894190 -
Development and Validation of the BVQ
|
||
Recruiting |
NCT04566523 -
TeleRehabilitation for Patients With Chronic Respiratory Failure.
|
||
Recruiting |
NCT04139356 -
The Effect of Spontaneous Respiration on Pulse-oximetry Measurements
|
N/A | |
Completed |
NCT03880630 -
Inspiratory Muscle Activation Pattern Analysis in Assisting Precision in Inspiratory Muscle Training in Patients With Chronic Respiratory Disease
|
N/A | |
Completed |
NCT03728595 -
Validation of a Predictive Score for HAST
|
||
Completed |
NCT03294057 -
Collaborative Care With Smart Health Management Program for Patients With Chronic Illness
|
N/A | |
Completed |
NCT03704935 -
Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program
|
||
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Recruiting |
NCT03797183 -
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
|
||
Enrolling by invitation |
NCT05724082 -
The Effect of Household Air Pollution on Lung Function Growth in Infants With Pneumonia in Sub-Saharan Africa
|
N/A | |
Completed |
NCT04623762 -
Yoga On Dyspnea, Sleep And Fatıgue In Chronıc Respıratory Dıseases
|
N/A | |
Not yet recruiting |
NCT06321471 -
AeviceMD for Pediatric Asthma Management
|
N/A | |
Not yet recruiting |
NCT06459011 -
Shedding Light on a Forgotten Workforce: Loved Ones of People With Chronic Respiratory Diseases
|
||
Recruiting |
NCT05248412 -
The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases
|
||
Not yet recruiting |
NCT04911764 -
Three-min Step Test and Exercise Desaturation Detection in Chronic Respiratory Insufficiency Patients
|
N/A | |
Completed |
NCT02715219 -
The Effect of an AEP on Patient's Knowledge Regarding Asthma Disease and Inhaler Technique: RCT
|
N/A | |
Completed |
NCT03799666 -
(Re)Vitalizing Pulmonary Rehabilitation for Patients With Chronic Respiratory Diseases
|
N/A | |
Completed |
NCT03188588 -
Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients
|
||
Completed |
NCT03930511 -
Telemonitoring Physical Activity in Daily Life on Chronic Respiratory Patients
|
N/A | |
Completed |
NCT04373070 -
Quality-of-Life Management for COPD Patients
|
N/A |